Xspray Pharma AB's total assets for Q4 2025 were kr769.35M, a decrease of -6.20% from the previous quarter. DE:6XP total liabilities were kr164.70M for the fiscal quarter, a -7.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.